Cargando…
Lentiviral Gene Transfer Corrects Immune Abnormalities in XIAP Deficiency
BACKGROUND: X-linked inhibitor of apoptosis protein (XIAP) deficiency is a severe immunodeficiency with clinical features including hemophagocytic lymphohistiocytosis (HLH) and inflammatory bowel disease (IBD) due to defective NOD2 responses. Management includes immunomodulatory therapies and hemato...
Autores principales: | Topal, Joseph, Panchal, Neelam, Barroeta, Amairelys, Roppelt, Anna, Mudde, Annelotte, Gaspar, H. Bobby, Thrasher, Adrian J., Houghton, Benjamin C., Booth, Claire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892131/ https://www.ncbi.nlm.nih.gov/pubmed/36329240 http://dx.doi.org/10.1007/s10875-022-01389-0 |
Ejemplares similares
-
Evolution of Our Understanding of XIAP Deficiency
por: Mudde, Anne C. A., et al.
Publicado: (2021) -
Transfer of gene-corrected T cells corrects humoral and cytotoxic defects in patients with X-linked lymphoproliferative disease
por: Panchal, Neelam, et al.
Publicado: (2018) -
Lentiviral Mediated ADA2 Gene Transfer Corrects the Defects Associated With Deficiency of Adenosine Deaminase Type 2
por: Hong, Ying, et al.
Publicado: (2022) -
Lentiviral Hematopoietic Stem Cell Gene Therapy Rescues Clinical Phenotypes in a Murine Model of Pompe Disease
por: Piras, Giuseppa, et al.
Publicado: (2020) -
Comparison of Lentiviral and Sleeping Beauty Mediated αβ T Cell Receptor Gene Transfer
por: Field, Anne-Christine, et al.
Publicado: (2013)